Pneumococcal infections risk factors

Jump to: navigation, search

Pneumococcal infections Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumococcal infections from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumococcal infections risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumococcal infections risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumococcal infections risk factors

CDC on Pneumococcal infections risk factors

Pneumococcal infections risk factors in the news

Blogs on Pneumococcal infections risk factors

Directions to Hospitals Treating Pneumococcal infections

Risk calculators and risk factors for Pneumococcal infections risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Risk Factors

The risk of pneumococcal infection is much increased in persons with impaired IgG synthesis, impaired phagocytosis, or defective clearance of pneumococci. In particular, the absence of a functional spleen, through congenital asplenia, splenectomy, or sickle-cell disease predisposes one to a more severe course of infection (Overwhelming post-splenectomy infection) and prevention measures are indicated (see asplenia). S. pneumoniae expresses different virulence factors on its cell surface and inside the organism. These virulence factors contribute to some of the clinical manifestations during infection with S. pneumoniae.

People whose immune system is compromised, such as those living with HIV, are also at higher risk of pneumococcal disease.[1] In HIV patients with access to treatment, the risk of invasive pneumoccal disease is 0.2%-1% per year and has a fatality rate of 8%.[1]

There is an association between pneumococcal pneumonia and influenza.[2] Damage to the lining of the airways (respiratory epithelium) caused by influenza may facilitate pneumococcal entry and infection.

Other risk factors include smoking, injection drug use, Hepatitis C, and COPD.[1]

References

  1. 1.0 1.1 1.2 Siemieniuk, Reed A.C. (2011). "The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study". BMC Infectious Diseases. 11 (314). doi:10.1186/1471-2334-11-314. PMC 3226630. PMID 22078162. Unknown parameter |coauthors= ignored (help); Unknown parameter |month= ignored (help)
  2. Walter ND, Taylor TH, Shay DK; et al. (2010). "Influenza Circulation and the Burden of Invasive Pneumococcal Pneumonia during a Non‐pandemic Period in the United States". Clin Infect Dis. 50 (2): 175–183. doi:10.1086/649208. PMID 20014948.



Linked-in.jpg